Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Folate Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Folate Market

5.1. Covid-19: Folate Industry Impact
5.2. Folate Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Folate Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Folate Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Folate Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing in fertility rate among women
6.1.1.2. Growing adoption of folic acid to treat kidney diseases
6.1.1.3. Increased health awareness among consumer
6.1.2. Market Restraints
6.1.2.1. Effect of high doses of folate
6.1.3. Market Opportunities
6.1.3.1. Advancements in the food service

Chapter 7. Global Folate Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Folate Market Revenue by Market Players
7.1.1.2. Folate Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Folate Market, By Type

8.1. Folate Market, by Type, 2023-2032
8.1.1. 5-MTHF Calcium Salt
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. 5-MTHF Glucosamine Salt
8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Folate Market, By End-use

9.1. Extrusion Sheet Market, by End-use, 2023-2032
9.1.1. Food & Beverages
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Pharmaceuticals & Nutraceuticals
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Agriculture & Feed
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Other End-Uses
9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Folate Market, By Form

10.1. Extrusion Sheet Market, by Form, 2023-2032
10.1.1. Tablets
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Capsules
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Powder
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Lozenges
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Gummies
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Folate Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Grade(2020-2032)
11.1.2. Market Revenue Forecast by End-use (2020-2032)
11.1.3. Market Revenue Forecast by Form (2020-2032)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2020-2032)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2020-2032)
11.2. Europe
11.2.1. Market Revenue Forecast by Grade (2020-2032)
11.2.2. Market Revenue Forecast by End-use (2020-2032)
11.2.3. Market Revenue Forecast by Form (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2020-2032)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2020-2032)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Grade (2020-2032)
11.3.2. Market Revenue Forecast by End-use (2020-2032)
11.3.3. Market Revenue Forecast by Form (2020-2032)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2020-2032)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2020-2032)
11.4. LATAM
11.4.1. Market Revenue Forecast by Grade (2020-2032)
11.4.2. Market Revenue Forecast by End-use (2020-2032)
11.4.3. Market Revenue Forecast by Form (2020-2032)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2020-2032)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2020-2032)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Grade (2020-2032)
11.5.2. Market Revenue Forecast by End-use (2020-2032)
11.5.3. Market Revenue Forecast by Form (2020-2032)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2020-2032)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2020-2032)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2020-2032)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2020-2032)

Chapter 12. Company Profiles

12.1. Gnosis SPA
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin
12.1.4. Recent Developments and Strategies
12.2. Merck
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin
12.2.4. Recent Developments and Strategies
12.3. BASF SE
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin
12.3.4. Recent Developments and Strategies
12.4. Koninklijke DSM N.V
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin
12.4.4. Recent Developments and Strategies
12.5. Medicamen Biotech Ltd.
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin
12.5.4. Recent Developments and Strategies
12.6. Emcure Pharmaceuticals Ltd.
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin
12.6.4. Recent Developments and Strategies
12.7. Jiangxi Tianxin Pharmaceutical Co. Ltd.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin
12.7.4. Recent Developments and Strategies
12.8. Seidler Chemical Co, Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin
12.8.4. Recent Developments and Strategies
12.9. Changzhou Niutang Chemical Plant Co. Ltd.
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin
12.9.4. Recent Developments and Strategies
12.10. Hebei Jiheng Group Pharmacy Co Ltd.
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin
12.10.4. Recent Developments and Strategies
12.11. Shandong Xinfa Pharmaceutical Co.
12.11.1. Company Overview, Business Information, Regional Presence
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue, Price, and Gross Margin
12.11.4. Recent Developments and Strategies
12.12. Nantong Changhai Food Additive
12.12.1. Company Overview, Business Information, Regional Presence
12.12.2. Product Portfolio Analysis
12.12.2.1. Product Details, Specification, Application
12.12.3. Revenue, Price, and Gross Margin
12.12.4. Recent Developments and Strategies
12.13. HEMA PHARMACEUTICALS PVT. LTD.
12.13.1. Company Overview, Business Information, Regional Presence
12.13.2. Product Portfolio Analysis
12.13.2.1. Product Details, Specification, Application
12.13.3. Revenue, Price, and Gross Margin
12.13.4. Recent Developments and Strategies
12.14. Superior Supplement Manufacturing
12.14.1. Company Overview, Business Information, Regional Presence
12.14.2. Product Portfolio Analysis
12.14.2.1. Product Details, Specification, Application
12.14.3. Revenue, Price, and Gross Margin
12.14.4. Recent Developments and Strategies
12.15. Gemini Pharmaceuticals, Inc.
12.15.1. Company Overview, Business Information, Regional Presence
12.15.2. Product Portfolio Analysis
12.15.2.1. Product Details, Specification, Application
12.15.3. Revenue, Price, and Gross Margin
12.15.4. Recent Developments and Strategies
12.16. Nutritional Supplement Manufacturers, Inc.
12.16.1. Company Overview, Business Information, Regional Presence
12.16.2. Product Portfolio Analysis
12.16.2.1. Product Details, Specification, Application
12.16.3. Revenue, Price, and Gross Margin
12.16.4. Recent Developments and Strategies
12.17. AIE Pharmaceuticals, Inc.
12.17.1. Company Overview, Business Information, Regional Presence
12.17.2. Product Portfolio Analysis
12.17.2.1. Product Details, Specification, Application
12.17.3. Revenue, Price, and Gross Margin
12.17.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms